We’ve Seen It All Before
Bill Evans, who heads up the Team Chemistry Digital group, makes the astute observation that in the current enthusiasm for social and mobile initiatives, each tactic should be considered in the light of real-world analytics and ROI.
The harsh lessons from the dot-com bust shouldn’t be ignored by the current generation of pharma marketers. He makes the point that the strength of digital is our ability to measure the effectiveness of each tactic, and weigh it against the investment required.
Read the full article at Dose of Digital